19 research outputs found
Life cycle assessment of an Internet of Things product : environmental impact of an intelligent smoke detector
Digitization and sustainability are the two big topics of our current time. As the usage of digital products like IoT devices continues to grow, it affects the energy consumption caused by the Internet. At the same time, more and more companies feel the need to become carbon neutral and sustainable. Determining the environmental impact of an IoT device is challenging, as the production of the hardware components should be considered and the electricity consumption of the Internet since this is the primary communication medium of an IoT device. Estimating the electricity consumption of the Internet itself is a complex task. We performed a life cycle assessment (LCA) to determine the environmental impact of an intelligent smoke detector sold in Germany, taking its whole life-cycle from cradle-to-grave into account. We applied the impact assessment method ReCiPe 2016 Midpoint and compared its results with ILCD 2011 Midpoint+ to check the robustness of our results. The LCA results showed that electricity consumption during the use phase is the main contributor to environmental impacts. The mining of coal causes this contribution, which is a part of the German electricity mix. Consequently, the smoke detector mainly contributes to the impact categories of freshwater and marine ecotoxicity, but only marginally to global warming
Fair and equitable AI in biomedical research and healthcare:Social science perspectives
Artificial intelligence (AI) offers opportunities but also challenges for biomedical research and healthcare. This position paper shares the results of the international conference âFair medicine and AIâ (online 3â5 March 2021). Scholars from science and technology studies (STS), gender studies, and ethics of science and technology formulated opportunities, challenges, and research and development desiderata for AI in healthcare. AI systems and solutions, which are being rapidly developed and applied, may have undesirable and unintended consequences including the risk of perpetuating health inequalities for marginalized groups. Socially robust development and implications of AI in healthcare require urgent investigation. There is a particular dearth of studies in human-AI interaction and how this may best be configured to dependably deliver safe, effective and equitable healthcare. To address these challenges, we need to establish diverse and interdisciplinary teams equipped to develop and apply medical AI in a fair, accountable and transparent manner. We formulate the importance of including social science perspectives in the development of intersectionally beneficent and equitable AI for biomedical research and healthcare, in part by strengthening AI health evaluation
Improvements in walking distance during nusinersen treatment: a prospective 3-year SMArtCARE Registry Study
Gender-biased attitudes and attributions among young italian children. Relation to peer dyadic interaction
In the present study, we examined gender-based social cognitions (i.e., global liking and trait attributions) related to observed dyadic peer interactions with same- and other-gender peers in a sample of young children from a large city in central Italy (N = 151; M age = 56.54 months). A multi-method procedure was used including observations of naturally occurring peer interactions and child reports of gender cognitions. Results showed that children interacted more in same-gender dyads than in other-gender dyads (i.e., gender segregation) and viewed same-gender peers more positively than other-gender peers (i.e., gender bias). However, this ingroup bias was found to be stronger for girls than for boys. In addition, findings revealed that for girls only, global liking and positive attributions were related to observed peer dyadic interactions. Specifically, girls who reported higher liking towards same-gender peers were observed to interact more in same-gender dyads. Moreover, the more girls reported liking same-gender peers and the more they viewed them as having positive characteristics, the less girls interacted in other-gender dyads. This result was consistent with our hypothesis about the relationship between gender cognitions and childrenâs peer interactions. Overall, these findings extend knowledge about the development of gender biases as early as preschool age and the role of gender cognitions on social interactions among young children
Leg ischemia: assessment with MR angiography and spectroscopy
PURPOSE: To prospectively determine reproducibility of magnetic resonance (MR) angiography and MR spectroscopy of deoxymyoglobin in assessment of collateral vessels and tissue perfusion in patients with critical limb ischemia (CLI) and to follow changes in patients undergoing intramuscular vascular endothelial growth factor (pVEGF)-C gene therapy, percutaneous transluminal angioplasty, supervised exercise training, or no therapy. MATERIALS AND METHODS: Study and gene therapy protocols were approved, and all patients gave written informed consent. To determine repeatability and reproducibility, seven patients underwent MR angiography and five underwent MR spectroscopy. The techniques were used to judge disease progress in 12 other patients with or without therapy: MR angiography to help determine change in visualization of collateral vessels and MR spectroscopy to help assess change in perfusion at proximal and distal calf levels. MR angiographic results were subjectively analyzed by three blinded readers. Intraobserver variability was expressed as 95% confidence interval (CI) (n=7); interobserver variability, as kappa statistic (n=15). Reexamination variability of MR spectroscopy was given as 95% CI for subsequent recovery times, and correlation with disease extent was calculated with Kendall taub rank correlation. Fisher-Yates test was used to correlate changes with pressure measurements and clinical course. RESULTS: Intraobserver and interobserver concordance was sensitive for detection of collateral vessels. Intraobserver agreement was 85.7% (95% CI: 42.1%, 99.6%). Interobserver agreement was high for small collateral vessels (kappa=0.74, P <.001) and fair for large collateral vessels (kappa=0.36, P=.002). MR spectroscopy was reproducible (95% CI: +/-26 seconds for proximal, +/-21 seconds for distal) and showed a correlation with disease extent (proximal calf, taub=0.84, P <.001; distal calf, taub=0.68, P=.04). Small collateral vessels increased over time (P=.04) but did not correlate with pressure measurements and clinical course. Recovery time correlated with clinical course (proximal calf, P=.03; distal calf, P=.005). CONCLUSION: MR angiography and MR spectroscopy of deoxymyoglobin can help document changes in visualization of collateral vessels and tissue perfusion in patients with CLI
Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer
Activated SUMOylation is a hallmark of cancer. Starting from a targeted screening for SUMO-regulated immune evasion mechanisms, we identified an evolutionarily conserved function of activated SUMOylation, which attenuated the immunogenicity of tumor cells. Activated SUMOylation allowed cancer cells to evade CD8+ T cellâmediated immunosurveillance by suppressing the MHC class I (MHC-I) antigen-processing and presentation machinery (APM). Loss of the MHC-I APM is a frequent cause of resistance to cancer immunotherapies, and the pharmacological inhibition of SUMOylation (SUMOi) resulted in reduced activity of the transcriptional repressor scaffold attachment factor B (SAFB) and induction of the MHC-I APM. Consequently, SUMOi enhanced the presentation of antigens and the susceptibility of tumor cells to CD8+ T cellâmediated killing. Importantly, SUMOi also triggered the activation of CD8+ T cells and thereby drove a feed-forward loop amplifying the specific antitumor immune response. In summary, we showed that activated SUMOylation allowed tumor cells to evade antitumor immunosurveillance, and we have expanded the understanding of SUMOi as a rational therapeutic strategy for enhancing the efficacy of cancer immunotherapies